Charles J. Fisher Jr. - 28 Jun 2021 Form 4 Insider Report for AETHLON MEDICAL INC (AEMD)

Role
Chief Executive Officer, Director
Signature
/s/ James B. Frakes, Attorney-in-Fact
Issuer symbol
AEMD
Transactions as of
28 Jun 2021
Net transactions value
$0
Form type
4
Filing time
30 Jun 2021, 14:23:49 UTC
Next filing
11 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEMD Employee Stock Option (Right to Buy) Award $0 +266,888 $0.000000 266,888 28 Jun 2021 Common Stock 266,888 $5.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the stock option shall vest and become exercisable on June 28, 2022, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter.